Philippe Camus, M.D.

Dijon, France

Both apps are now back!

Back to drug

The Drug-Induced Respiratory Disease Website and App

Frequency - Incidence

Incidence of respiratory adverse event(s) due to the specific drug as assessed by number of reported/published cases in the literature. Red digits in stars indicate: 0 = Very rare, questionable signal · 1 = < 10 cases · 2 = 10-50 cases · 3 = 50–100 cases · 4 = 100-200 cases · 5 = >200 cases

Evidence level/grade

Evidence level for respiratory adverse event(s) due to the specific drug as estimated using Hill’s (1965), Naranjo’s (1981), and Bégaud’s (1985) criteria applied to published cases. Blue digits in stars indicate: 0 = Questionable · 1 = Low · 2 = Moderate · 3 = Robust · 4 = Definite · 5 = Unquestionable, pathognomonic

LI.r

Pericarditis (see also under XIIc)

Publications

Conte C, Princi G, D'Amario D, Sanna T, Pedicino D, Liuzzo G

Incessant pericarditis following the second dose of SARS-CoV-2 mRNA vaccine successfully treated with anakinra: a case report.

European heart journal. Case reports 2022 Sep;6;ytac357 — 2022 Sep — ytac357

Singh A, Nguyen L, Everest S, Afzal S, Shim A

Acute Pericarditis Post mRNA-1273 COVID Vaccine Booster.

Cureus 2022 Feb;14;e22148 — 2022 Feb — e22148

Vidula MK, Ambrose M, Glassberg H, Chokshi N, Chen T, Ferrari VA, Han Y

Myocarditis and Other Cardiovascular Complications of the mRNA-Based COVID-19 Vaccines.

Cureus 2021 Jun;13;e15576 — 2021 Jun — e15576

Wise J

Covid-19: Should we be worried about reports of myocarditis and pericarditis after mRNA vaccines?

BMJ (Clinical research ed.) 2021 Jun 24;373;n1635 — 2021 Jun 24 — n1635

Furer V, Eviatar T, Zisman D, Peleg H, Paran D, Levartovsky D, Zisapel M, Elalouf O, Kaufman I, Meidan R, Broyde A, Polachek A, Wollman J, Litinsky I, Meridor K, Nochomovitz H, Silberman A, Rosenberg D, Feld J, Haddad A, Gazzit T, Elias M, Higazi N, Kharo

Immunogenicity and safety of the BNT162b2 mRNA COVID-19 vaccine in adult patients with autoimmune inflammatory rheumatic diseases and in the general population: a multicentre study.

Annals of the rheumatic diseases 2021 Jun 14;; — 2021 Jun 14